RNLXY
RNLXY clinical trials: Renalytix plc
Every trial on ClinicalTrials.gov where Renalytix plc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
RNLXY on the catalyst calendar · RNLXY registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 1, 2023Actual | NCT05198284Prospective Decision Impact Clinical Utility Trial of KidneyIntelXRenalytix AI, Inc. · Diabetic Kidney Disease | RNLXYLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Dec 1, 2023Actual | NCT04960514Prospective Decision Impact Trial of KidneyIntelXRenalytix AI, Inc. · Diabetic Kidney Disease | RNLXYLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Dec 1, 2026Sponsor estimate | NCT04802395Real World Evidence Clinical Utility Study of KidneyIntelXRenalytix AI, Inc. · Chronic Kidney Diseases | RNLXYLead | No phase registered | Recruiting | Locked | Locked | Locked |
| Nov 1, 2026Sponsor estimate | NCT04791358Decision Impact Trial of KidneyIntelXRenalytix AI, Inc. · Diabetic Kidney Disease | RNLXYLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
- Primary completion Dec 1, 2023ActualNo phase registeredNCT05198284Prospective Decision Impact Clinical Utility Trial of KidneyIntelXRenalytix AI, Inc. · Diabetic Kidney DiseaseActive, not recruitingRNLXYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2023ActualNo phase registeredNCT04960514Prospective Decision Impact Trial of KidneyIntelXRenalytix AI, Inc. · Diabetic Kidney DiseaseActive, not recruitingRNLXYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2026Sponsor estimateNo phase registeredNCT04802395Real World Evidence Clinical Utility Study of KidneyIntelXRenalytix AI, Inc. · Chronic Kidney DiseasesRecruitingRNLXYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 1, 2026Sponsor estimateNo phase registeredNCT04791358Decision Impact Trial of KidneyIntelXRenalytix AI, Inc. · Diabetic Kidney DiseaseActive, not recruitingRNLXYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner